Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001966716-26-000008

GENERAL COUNSEL & CORP SEC sold 9,293 shares at an average $33.69 ($313,038)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-20 Sale 10b5-1 −8,692 $33.64 $292,359 20,144 D: show line 1 in the form
Allan Jonathan GENERAL COUNSEL & CORP SEC 2026-03-20 Sale 10b5-1 −601 $34.41 $20,679 19,543 D: show line 2 in the form
Open-market sales · 9,293 sh · avg $33.69 · $313,038
Loading xslF345X06/form4-03242026_080316.xml…